Lipton Rogers, the developer behind 22 Bishopsgate, has joined forces with London-based start-up Galileo Labs in a bid to gain a £1.5bn foothold in the life sciences market.
The pair plans to amass a £1.5bn life sciences
Lipton makes life sciences debut with £1.5bn jv
